APA (7th ed.) Citation

A, J. J., N, C. d. G., H, M. R., M, S. L., MR, M., & R, P. V. (2017). Hepatitis B virus reactivation after cessation of prophylaxis with entecavir in a patient with Burkitt type acute lymphoblastic leukaemia treated with rituximab. Gastroenterologia y hepatologia, 40(7), 470. https://doi.org/10.1016/j.gastrohep.2016.08.005

Chicago Style (17th ed.) Citation

A, Juan Juan, Caballero de García N, Masnou Ridaura H, Sala Llinas M, Morillas MR, and Planas Vila R. "Hepatitis B Virus Reactivation After Cessation of Prophylaxis with Entecavir in a Patient with Burkitt Type Acute Lymphoblastic Leukaemia Treated with Rituximab." Gastroenterologia Y Hepatologia 40, no. 7 (2017): 470. https://doi.org/10.1016/j.gastrohep.2016.08.005.

MLA (9th ed.) Citation

A, Juan Juan, et al. "Hepatitis B Virus Reactivation After Cessation of Prophylaxis with Entecavir in a Patient with Burkitt Type Acute Lymphoblastic Leukaemia Treated with Rituximab." Gastroenterologia Y Hepatologia, vol. 40, no. 7, 2017, p. 470, https://doi.org/10.1016/j.gastrohep.2016.08.005.